Replies to post #354552 on Amarin Corp Plc (AMRN)

[couldbebetter]

Sstyles, Pfizer could drive Vascepa's success on so many levels:
1. Superior marketing/existing army of sales reps around the world.
2. Influence with the FDA. (Maybe quash fish oil dietary supplements.)
3. Could promote the use of Vascepa to treat inflammation from C-19 and
the vaccines.
4. Could provide support or structure a deal to co-promote/market Vascepa
with Eddingpharm in China.
5. Pfizer is riding a wave of goodwill from its C-19 vaccine. If Pfizer
began promoting Vascepa with a "worldwide campaign to tackle CVD,
the greatest killer on the planet," people would listen...Pfizer
could promote it as another way they are saving lives around the
world. They could pull that off. Amarin in GIA mode? Not so much.